THE problem of systemic arterial embolism in rheumatic heart disease does not end after the patient has survived the acute episode. As protection from re-embolism, which threatens in some 45 per cent ...

Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...

Surgically ligating the left atrial appendage (LAA) during implantation of the HeartMate 3 left ventricular assist device (LVAD; Abbott) does not affect survival or hemocompatibility-related adverse ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

You have full access to this article via your institution. In the referenced study from our centre (which also states the potential limitations of the study) 3, we have further validated the long-term ...